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Low lean bodymass (LBM) is related to a series of health problems, such as osteoporotic fracture and sarcopenia.Herewe report a genome-
wide association (GWA) study on LBM variation, by using Affymetrix 500K single-nucleotide polymorphism (SNP) arrays. In the GWA
scan, we tested 379,319 eligible SNPs in 1,000 unrelated US whites and found that two SNPs, rs16892496 (p ¼ 7.55 3 108)
and rs7832552 (p ¼ 7.58 3 108), within the thyrotropin-releasing hormone receptor (TRHR) gene were signiﬁcantly associated with
LBM. Subjects carrying unfavorable genotypes at rs16892496 and rs7832552 had, on average, 2.70 and 2.55 kg lower LBM, respectively,
compared to thosewith alternative genotypes.We replicated the signiﬁcant associations in three independent samples: (1) 1488unrelated
US whites, (2) 2955 Chinese unrelated subjects, and (3) 593 nuclear families comprising 1972 US whites. Meta-analyses of the GWA scan
and the replication studies yielded p values of 5.53 3 109 for rs16892496 and 3.88 3 1010 for rs7832552. In addition, we found
signiﬁcant interactions between rs16892496 and polymorphisms of several other genes involved in the hypothalamic-pituitary-thyroid
and the growthhormone-insulin-like growth factor-I axes. Results of this study, together with the functional relevance of TRHR inmuscle
metabolism, support the TRHR gene as an important gene for LBM variation.Loss and function impairment of skeletal muscle in the
elderly is related to a series of diseases or health problems,
such as sarcopenia,1 mobility limitation, osteoporosis
(MIM 166710), higher risk of fracture, impaired protein
balance, dyslipidemia (MIM 151660), obesity (MIM
601665), insulin resistance, overall frailty, and increased
mortality.2,3 Lean body mass (LBM) measured by dual
energy X-ray absorptionmetry (DXA) is a good index for
quantity and quality of skeletal muscle.4 LBM is under
strong genetic determination with heritability ranging
from 52% to 84%.5–7 However, speciﬁc genes underlying
variation in LBM are largely unknown.
Here we report a genome-wide association (GWA) study
for LBM by using Affymetrix 500K SNP arrays in a sample
of 1000 unrelated US whites. The interested associations
were further replicated in three independent samples,
including an unrelated US white sample comprising 1488
subjects, 593 nuclear families comprising 1972 US whites,
and an unrelated Chinese sample comprising 2955
subjects.
All our study subjects of US whites were identiﬁed from
an established cohort containing ~6000 subjects recruited
from the Midwestern US. This cohort was initiated to
search quantitative trait loci and/or genes underlying
body compositions (bone mass for osteoporosis, fat body
mass for obesity, and lean body mass for sarcopenia418 The American Journal of Human Genetics 84, 418–423, March 1studies). The inclusion and exclusion criteria have been
described in detail elsewhere.8 The Chinese sample
contains 2955 healthy Chinese Han adults living in
Changsha City, China. The same inclusion and exclusion
criteria used for the white subjects were applied in the
recruitment of the Chinese sample. All studies were
approved by local Institutional Review Boards. Signed
informed-consent documents were obtained from all study
participants.
LBM and fat body mass were measured with Hologic
DXA 4500 machines (Hologic Inc., Bedford, MA) for all
the study samples. Anthropometric measures and a struc-
tured questionnaire covering lifestyle, diet, family infor-
mation, medical history, etc. were obtained for all the
study subjects. Body mass index (BMI) was calculated as
the ratio of weight to square of height in unit of kg/m2.
The basic characteristics of all the four study samples are
provided in Table 1.
For the GWA scan, genotyping was performed for
1000 US whites with the GeneChip Human Mapping
500K Array Set (Affymetrix, Santa Clara, CA) by the
Vanderbilt Microarray Shared Resource (Vanderbilt Univer-
sity Medical Center, Nashville, TN) with the standard
protocol recommended by the manufacturer. Genotyping
calls were determined with the DM algorithm9 with
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algorithm.10 DM calls were used for quality control of the
genotyping experiment, and unsatisfactory arrays were
subject to regenotyping. Eventually, 997 subjects who
had at least one array (Nsp or Sty) reaching 93% call rate
were retained. Because of missing data of LBM or applied
covariates among the 997 subjects, the effective sample
size for the GWA scan is 973. The average call rate for the
973 analyzed subjects reached >95%. BRLMM calls were
used for the association analyses. The ﬁnal average
BRLMM call rate in the GWA cohort reached 99.27%.
Out of the initial full set of 500,568 SNPs, we discarded
32,961 SNPs with SNP-wised call rate <95%, 36,965 SNPs
with allele frequencies deviating from Hardy-Weinberg
equilibrium (HWE) (p < 0.001), and 51,323 SNPs with
minor allele frequency (MAF) <1%. Therefore, the ﬁnal
SNP set for the GWA scan contained 379,319 SNPs,
yielding a genomic marker spacing of ~7.9 kb on average.
For replication studies in the US white samples, genotyp-
ing was performed by KBioscience (Herts, UK) with the
technology of competitive allele-speciﬁc PCR (KASPar).
The replication rate (duplicate concordance rate) was
99.7% for genotyping and the average call rate was
97.8%. For the replication study in the Chinese sample,
SNP genotyping was performed with a primer-extension
method with MALDI-TOF mass spectrometry on a
MassARRAY system as suggested by the manufacturer
(Sequenom, Inc., San Diego, CA). The replication rate is
99.2% and the average call rate is 97.2%.
Table 1. Basic Characteristics of the Study Samples
Sample and Trait Males Females
Initial GWA study n ¼ 492 n ¼ 481
Age (years) 50.52 (18.89) 50.13 (17.13)
Height (m) 1.78 (0.070) 1.64 (0.065)
Lean body mass (kg) 63.67 (8.22) 43.49 (6.69)
Fat body mass (kg) 23.46 (8.88) 26.92 (10.33)
BMI (kg/m2) 28.92 (4.30) 27.29 (5.98)
Replication study in US
white population
n ¼ 659 n ¼ 829
Age (years) 63.18 (10.27) 61.71 (10.72)
Height (m) 1.77 (0.06) 1.62 (0.07)
Lean body mass (kg) 65.09 (9.21) 45.16 (6.84)
Fat body mass (kg) 25.06 (8.04) 28.78 (9.79)
BMI (kg/m2) 29.19 (4.50) 27.83 (5.65)
Replication study in
Chinese population
n ¼ 1437 n ¼ 1518
Age (years) 30.53 (12.54) 35.44 (15.74)
Height (m) 1.69 (0.06) 1.58 (0.05)
Lean body mass (kg) 51.80 (5.76) 37.39 (4.21)
Fat body mass (kg) 11.33 (5.22) 15.56 (5.07)
BMI (kg/m2) 22.24 (2.90) 21.38 (3.15)
Replication study in US
white families
n ¼ 570 n ¼ 1402
Age (years) 52.89 (16.22) 47.45 (15.24)
Height (m) 1.78 (0.08) 1.64 (0.06)
Lean body mass (kg) 65.88 (9.37) 45.72 (7.13)
Fat body mass (kg) 23.24 (8.92) 26.01 (10.42)
BMI (kg/m2) 28.83 (6.30) 26.84 (5.91)
Note: Data presented are unadjusted means (SD).The AmeTocontrolpotentialpopulationstratiﬁcation thatmay lead
to spurious association results,weused the software Structure
2.211 to investigate the population structure of the GWA
cohort. With 200 randomly selected unlinked SNPs, all the
973 subjects were tightly clustered together under all the
three assumed number of population strata (i.e., k ¼ 2, 3, or
4), suggesting no signiﬁcant population substructure.
For both the initial GWA scan and subsequent replica-
tion studies, stepwise regression was performed to screen
the effects of age, sex, age2, age-by-sex interaction, and
fat body mass on LBM variation. Age, sex, and fat body
mass were signiﬁcant effectors (p < 0.05) and raw LBM
values were adjusted for these factors. The adjusted pheno-
type values, if departing from normal distribution, were
further subjected to BoxCox transformation to ensure
the normality with the software Minitab (Minitab Inc.,
State College, PA). F-tests were conducted to achieve the
genotype-wise association tests for the unrelated samples,
whereas the FBAT method was used for association tests
in the family-based sample. All the association analyses
were performed with the software HelixTree 5.3.1, in
which FBAT was implemented.12 To further ensure robust-
ness of the association tests, we also used EIGENSTRAT13 to
perform GWA analyses and cross-check the results against
those obtained with HelixTree. EIGENSTRAT can detect
and correct for potential population admixture and differ-
ences in laboratory treatment among samples.13
We adopted the conservative Bonferroni method to
account for themultiple-testing problem in theGWAstudy.
Because 379,319 eligible SNPs were eventually tested, the
signiﬁcance level for the GWA scan was set as 1.32 3 107
(i.e., 0.05/379319). The quantile-quantile (Q-Q) plotting
method was used to determine the signiﬁcance level for
‘‘suggestive association.’’ The Q-Q plot was constructed by
ranking the observed p values from smallest to largest and
plotting them against the same ordered p values under
the null hypothesis of no association (expected p values).
We calculated the expected p values for 1000 times and
superimposed them in the Q-Q plot to construct a 95%
concentration band after the method proposed by Stir-
ling.14 Deviations from the band in the Q-Q plot suggest
that the corresponding associations are highly likely to be
true ones;15 therefore, we took the p value at the point of
deviation (p < 1.26 3 104, Figure S1 available online) as
the threshold for suggestive associations.
Point estimates and their standard errors for per-allele
effect sizes of the favorable alleles of interested SNPs on
LBM were calculated through linear regression analyses
with SAS 9.1 (SAS Institute Inc., Cary, NC). The effect
estimate and standard error of the most signiﬁcant SNP for
each separate association analysis in the initial GWA scan
and subsequent replication studies were combined in the
meta-analysis via the inversevariancemethod implemented
in the software Comprehensive Meta Analysis.
In the GWA scan, we identiﬁed two genome-level signif-
icant SNPs (p values of 7.55 3 108 and 7.58 3 108 for
rs16892496 and rs7832552, respectively), and other 146rican Journal of Human Genetics 84, 418–423, March 13, 2009 419
suggestive SNPs associated with LBM (Figure 1, Table S1).
The two SNPs showing genome-level signiﬁcant associa-
tions with LBM are located in the only intron of the thyro-
tropin-releasing hormone receptor (TRHR) gene (MIM
188545) (Figure 2). These two SNPs also achieved the stron-
gest associations with LBM in EIGENSTRAT analyses with
p values of 1.42 3 107 and 1.79 3 107 for rs16892496
and rs7832552, respectively. Interestingly, 15 other SNPs
of the TRHR gene also showed suggestive associations
with LBM (Table 2, Figure 2). The two most signiﬁcant
SNPs, rs16892496 and rs7832552, are in strong linkage
disequilibrium (LD) (r2 ¼ 0.98). Compared to subjects
carrying TT or GT genotypes at rs16892496, those carrying
the GG genotype had 2.70 kg higher LBM, on average.
Similarly, subjects carrying the TT genotype at rs7832552
had 2.55 kg higher LBM compared to subjects with CC
or CT genotypes.
The replication studies largely conﬁrmed the signiﬁcant
ﬁndings in the GWA scan (Table 3). The association of
rs16892496 with LBM was replicated in the independent
unrelated US white sample and unrelated Chinese sample
(p ¼ 0.018 and 0.013, respectively; Table 3). The SNP
rs7832552 was consistently and signiﬁcantly associated
with LBM in all the three replication samples. Meta-
analyses of the initial GWA scan and replication studies
achieved the combined p values of 5.53 3 109 for
Figure 1. Results of the GWA Scan for Lean Body Mass
The y axis represents –log10P. Both height and colors of the bars correspond to p values of the SNPs, which are arranged along the x axis
according to their physical position on chromosomes.
Figure 2. Association Signals and LD
Structure of the TRHR Gene SNPs
(A) Association results for SNPs of the
TRHR gene in the GWA scan. The y axis
shows –log10P of the association results
and the x axis shows the physical position
(Mb) on chromosome 8.
(B) Position of the TRHR gene and the
tested SNPs. The TRHR gene was repre-
sented with two red bars for exons and
a red line for intron. The red arrow denotes
the transcriptional direction of the TRHR
gene. SNPs were illustrated by vertical
lines. Lines above the horizontal axis
represent SNPs showing significant and
suggestive associations with LBM.
(C) The LD structure of the tested SNPs. LD
pattern was analyzed in our GWA sample
and plotted with the Haploview program.420 The American Journal of Human Genetics 84, 418–423, March 13, 2009
Table 2. Association Results for SNPs of the TRHR Gene in the GWA Scan
SNP Position Role Allelesa MAFb p Value Effect Sizec Favorable Alleled
rs4236794 109955588 upstream C/T 0.37 0.3 0.043 (0.031) T
rs4617129 109956715 upstream G/A 0.33 0.14 0.034 (0.032) A
rs4639483 109965846 upstream C/T 0.38 0.12 0.055 (0.033) T
rs6469211 109976702 upstream C/T 0.34 0.11 0.038 (0.032) T
rs12543698 109996108 upstream A/T 0.2 1.86 3 103 0.028 (0.032) A
rs10098562 110022238 upstream T/C 0.04 0.6 0.036 (0.032) T
rs10086780 110047705 upstream G/A 0.29 0.28 0.021 (0.030) G
rs6469224 110124863 upstream A/G 0.46 4.69 3 103 0.086 (0.032) G
rs4276659 110133336 upstream C/A 0.44 1.94 3 103 0.081 (0.032) A
rs4631432 110143381 upstream A/G 0.4 1.73 3 103 0.096 (0.032) G
rs4349964 110144137 upstream A/G 0.41 1.38 3 103 0.094 (0.032) G
rs4469428 110144284 upstream A/G 0.41 1.23 3 103 0.082 (0.032) G
rs4735085 110145588 upstream C/A 0.32 0.6 0.033 (0.030) A
rs4506180 110154994 upstream A/C 0.5 7.87 3 103 0.046 (0.030) A
rs4466373 110155042 upstream T/C 0.21 7.41 3 106 0.061 (0.032) T
rs4297015 110155444 upstream T/C 0.18 9.69 3 103 0.028 (0.032) C
rs7012225 110156031 upstream G/A 0.18 0.07 0.042 (0.030) G
rs6469232 110157417 upstream T/C 0.11 0.3 0.031 (0.032) C
rs3134106 110170951 intron A/C 0.17 0.06 0.044 (0.032) A
rs3134115 110175985 intron A/G 0.4 8.69 3 104 0.079 (0.032) G
rs12544197 110177001 intron A/G 0.48 1.17 3 103 0.037 (0.032) A
rs7829028 110178706 intron T/C 0.0971 0.36 0.026 (0.032) C
rs16892496 110179027 intron G/T 0.32 7.55 3 108 0.107 (0.032) G
rs7832552 110184852 intron T/C 0.32 7.58 3 108 0.102 (0.030) T
rs3925087 110191854 intron C/T 0.36 4.34 3 106 0.096 (0.032) C
rs4546626 110194938 intron G/T 0.36 1.37 3 105 0.077 (0.032) G
rs4735098 110225067 downstream G/A 0.38 2.57 3 106 0.082 (0.030) G
rs4314624 110235192 downstream C/G 0.35 2.42 3 105 0.078 (0.032) C
rs4607576 110235212 downstream T/C 0.35 2.65 3 105 0.078 (0.032) T
rs4628236 110241321 downstream T/C 0.35 3.09 3 105 0.073 (0.032) T
rs7845815 110247020 downstream A/G 0.35 2.04 3 105 0.075 (0.032) A
rs4734197 110247681 downstream G/A 0.34 2.39 3 105 0.079 (0.032) G
rs10111874 110254194 downstream G/A 0.35 2.35 3 105 0.075 (0.032) G
rs10112296 110254469 downstream T/C 0.35 6.20 3 105 0.072 (0.032) T
rs11785243 110259359 downstream A/G 0.36 3.12 3 105 0.075 (0.032) A
rs10087444 110288911 downstream A/G 0.44 0.06 0.035 (0.030) G
rs6469245 110289983 downstream C/G 0.41 9.42 3 105 0.076 (0.030) C
rs4735116 110290780 downstream G/T 0.41 8.51 3 105 0.075 (0.030) G
rs1380098 110317808 downstream A/G 0.41 6.28 3 105 0.069 (0.032) A
Note: The two SNPs significantly associated with lean body mass after Bonferroni correction in the GWA scan are shown in italics and bold.
a The former allele represents the minor allele of each locus in our GWA sample.
b Minor allele frequency calculated in our GWA sample.
c Per-allele effect size of the favorable allele is expressed by beta coefficients derived from linear regression analyses.
d Subjects with more favorable alleles generally have higher values of lean body mass than subjects having alternative genotypes in the population.rs16892496 and 3.88 3 1010 for rs7832552, respectively.
A forest plot for the association between rs16892496 and
LBM is given in Figure 3.
TRHR encodes the thyrotropin-releasing hormone
receptor,whichbelongs to theGprotein-coupled receptor 1
family. Thyrotropic-releasinghormone (TRH) is a tripeptide
(Glu-His-Pro) hormone secreted by the hypothalamus.
TRH exerts its effect by binding to TRHR on the surface
of pituitary thyrotrophs. The primary consequence of
TRH:TRHR binding is activation of the inositol phospho-
lipid-calcium-protein kinase C transduction pathway,
which, in turn, stimulates secretion of thyroid-stimulating
hormone (TSH) and prolactin (PRL). The TSH response to
TRHR is the ﬁrst step in the hormonal cascade of hypotha-
lamic-pituitary-thyroid axis (HPTA) that eventually leadsThe Amerto the release of thyroxin, which is important in the devel-
opment of vertebrate skeletal muscle.16 Mutations in the
TRHRgenemaydecrease afﬁnityofTRHR forTRHand result
in central hypothyroidism,17 which causes impaired
expression of myosin heavy chain (MHC) isoforms18 and
diminished muscle cross-sectional areas.19 Furthermore,
thyroxin is necessary for full anabolic action of the growth
hormone-insulin-like growth factor-I (GH-IGF1) axis,20
which plays an important role in muscle protein balance
and adaptative changes to load.21,22
Motivated by known physiological relevance of TRHR to
the HPTA and GH-IGF1 pathways, we further performed
interaction analyses for SNP rs16892496 in the TRHR
gene, which showed the most signiﬁcant association with
LBM in the GWA scan, with 912 SNPs in other 33 genesican Journal of Human Genetics 84, 418–423, March 13, 2009 421
Table 3. Association Results between Lean Body Mass and the Two Significant TRHR SNPs in the GWA Scan and Three Replication
Studies and Meta-analyses
Replication Studiesa
SNP
Discovery Scan
(n ¼ 973)
Sample 1
(n ¼ 1488)
Sample 2
(n ¼ 2955)
Sample 3b
(n ¼ 1972)
Combinedc
(n ¼ 7415)
rs16892496 7.55 3 108
(0.1075 0.032)
0.018 (0.1125 0.038) 0.013 (0.0745 0.024) 0.083 (0.0875 0.029) 5.53 3 109
(0.0905 0.015)
rs7832552 7.58 3 108
(0.1025 0.030)
0.0056 (0.1055 0.036) 0.012 (0.0765 0.024) 0.015 (0.0815 0.028) 3.88 3 1010
(0.0615 0.014)
Values in the table are p values followed by the point estimates of effect sizes expressed by beta coefficients5 standard errors.
a The replication studies were performed in three samples: Sample 1, the independent unrelated US white sample; Sample 2, the unrelated Chinese sample;
Sample 3, the family-based US white sample.
b The effect sizes for sample 3 were calculated in founders.
c Accumulative p values and beta coefficients were generated under the random-effect model.putatively involved in the HPTA and GH-IGF1 pathways
(Table S2). The most signiﬁcant interaction with
rs16892496 was detected for SNP rs12474719 (p ¼ 6.04 3
1011) of the insulin-like growth factor binding protein 5
(IGFBP5) gene. A joint modeling of rs16892496 and
rs12474719 increased the LBM variation explained solely
by rs16892496 from 2.29% to 2.91%.
To our knowledge, this is the ﬁrst GWA study for LBM
variation. We identiﬁed a signiﬁcant association between
the TRHR gene and LBM variation. The association ﬁnd-
ings were further supported by three independent replica-
tion studies in both US white subjects and Chinese Han
population. In addition, we found that LBM variation is
inﬂuenced by interactions between TRHR and several
other genes involved in the HPTA and GH-IGF1 pathways.
The identiﬁed association between TRHR SNPs and LBM
are unlikely to be artifacts. First, conservative Bonferroni
correction was used to claim signiﬁcant associations in
the initial GWA scan. In addition, besides the two SNPs
Figure 3. Forest Plot for the Association between rs16892496
and LBM
Black boxes denote point estimates for effect sizes (beta coeffi-
cients) in corresponding association studies, and the sizes of the
box are proportional to the inverse variance weight of the estimate
in the meta-analysis. Horizontal lines represent 95% confidence
intervals (CIs). The diamond represents the accumulative beta
coefficient computed under the random-effect model, with the
95% CI given by its width. The scale of the plot was indicated by
the bottom values. Samples 1–3 represent the three samples
used for the replication studies, with #1 for the unrelated US white
sample, #2 for the unrelated Chinese sample, and #3 for the family-
based US white sample.422 The American Journal of Human Genetics 84, 418–423, March 1achieving genome-level association signal with LBM, 15
other SNPs of the TRHR gene got suggestive association
signals in the GWA scan. Thus, individual genotyping
errors are unlikely to be responsible for these associations.
Moreover, we strictly controlled potential population strat-
iﬁcation by using Structure and EIGENSTRAT. Genomic
control analyses23 showed a small inﬂation factor of
1.036. Most importantly, the signiﬁcant associations
were replicated in three independent samples.
LBM accounts for ~60% or more of body weight and
thus may signiﬁcantly contribute to variation in BMI,
an index commonly used for obesity.24 Interestingly,
previous linkage studies found that a locus at 8q23, which
spans the TRHR gene, was linked to BMI.25,26 We specu-
late that the observed linkage may be partially attributable
to the association between TRHR and LBM. As a support
of the speculated effect of the GH-IGF1 pathway on
LBM, the insulin-like growth factor 1 receptor (IGF1R)
gene and the GHRH gene were also linked to fat-free
mass in previous studies.27
In summary, our GWA scan and multiple replication
studies, in conjunction with the known functional
involvement of TRHR in muscle metabolism, suggest that
polymorphisms in TRHR gene, and possibly other genes
in the HPTA and GH-IGF1 pathways, signiﬁcantly
contribute to LBM variation. The mechanisms underlying
the observed associations merit further investigation.
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